CRI Investigator Named to Top Position at U.K. Immunology Research Group
Cancer Research Institute – 7/21/10 – Cancer Research Institute clinical investigator Vincenzo Cerundolo, a professor of immunology at the Weatherall Institute of Molecular Medicine at the University of Oxford, U.K., has been named director of the Medical Research Council (MRC) Human Immunology Unit.
See all headlines >>
Cervical cancer vaccine 'may prevent more cases than initially thought'
Cancer Research UK – 7/14/10 – A study by scientists at the Health Protection Agency, the University of Manchester, and the Manchester Royal Infirmary suggests that the cervical cancer vaccine could prevent even more cases of the disease than previously thought. (Click here for more information on the cervical cancer vaccine and CRI’s role in it.)
See all headlines >>
Test could predict which children with T-cell acute lymphoblastic leukemia are best candidates for clinical trials of new therapies
Dana-Farber – 7/19/10 – CRI Investigator Adolfo Ferrando, M.D., Ph.D., at Columbia University, named as co-author on publication in the Journal of Clinical Oncology on this discovery of a new genetic marker that enables doctors to predict, for the first time, which children with T-cell acute lymphoblastic leukemia (T-ALL) are unlikely to benefit from standard chemotherapy.
See all headlines >>
CRI Scientific Advisory Council Member Dr. Richard Lerner to be Honored by University of Warwick
University of Warwick – 7/15/10 – University of Warwick to award twelve honorary degrees during its Summer degree ceremonies next week, including an Honorary Doctor of Science to CRI Scientific Advisory Council member Dr. Richard Lerner.
See all headlines >>
Medicare to Weigh Coverage for Dendreon Drug
Wall Street Journal – 6/30/10 – The Center for Medicare and Medicaid Services will conduct a year-long analysis to weigh national coverage for Dendreon’s new prostate cancer vaccine Provenge®, which was approved by the FDA in April 2010. In the meantime, regional providers can determine whether or not to cover it. (Click here for more CRI news on Provenge and prostate cancer.)
See all headlines >>
Pancreatic Cancer Vaccine Advances
CBS News – 6/30/10 – Video: Researchers at Johns Hopkins Medical Center report progress on a pancreatic cancer vaccine.
See all headlines >>
CRI Fellow Jesse D. Bloom, Ph.D., Provides Molecular Explanation for the Evolution of Virus Resistance to Tamiflu
Nano Patents and Innovations – 6/6/10 – CRI Fellow Jesse Bloom, Ph.D., at the California Institute of Technology identified molecular changes that helped facilitate the global spread of resistance to the antiviral medication Tamiflu (oseltamivir) among strains of the seasonal H1N1 flu virus.
See all headlines >>
CRI Scientists James Allison, Ph.D., and Jedd Wolchok, M.D., Ph.D., featured on ABC
WABC – 6/23/10 – CRI scientists James Allison, Ph.D., and Jedd Wolchok, M.D., Ph.D., featured in ABS news story on the new immunotherapy for melanoma, ipilimumab. (Click here for more CRI news on ipilimumab and melanoma.)
See all headlines >>
New Cancer Immunotherapy Helps Patients with Metastatic Melanoma Live Longer
CRI – 6/7/10 – A new treatment for melanoma "takes the brakes off the immune system" and extends survival
See all headlines >>
CRI Announces 2010 William B. Coley Award Winners
CRI – 6/7/10 – Three scientists will receive the prestigious Coley Award for contributions to tumor immunology that have bolstered efforts to create vaccines to treat, control, and prevent cancer.
See all headlines >>
FDA Approves Prostate Cancer Vaccine
CRI – 4/30/10 – Yesterday's announcement of the first FDA approval for a therapeutic cancer vaccine heralds the start of a new era in cancer treatment, CRI scientists say.
See all headlines >>
MEDIA ALERT: 28th Annual Through the Kitchen Party at The Four Seasons
CRI – 4/13/10 – Called 'one of the most memorable parties of 2009' by the New York Times, "Through the Kitchen" is a festive evening that raises funds to support young postdoctoral researchers working in leading immunology and tumor immunology laboratories around the world.
See all headlines >>
Eating vegetables doesn't stop cancer
NY Times – 4/7/10 – A diet rich in fruits and vegetables was associated with only a small reduction in cancer risk, according to researchers who studied the eating habits of more than 400,000 people for nearly nine years.
See all headlines >>
New technology from CRI scientists improves immune monitoring of therapeutic cancer vaccines
CRI – 4/7/10 – Measuring a key immunology indicator of successful treatment with a therapeutic cancer vaccine just got easier, thanks to a new test established by a collaboration of scientists in France and Switzerland.
See all headlines >>
Researchers see a revolution in cancer vaccines on the horizon
Fierce Vaccines – 4/7/10 – A number of therapeutic cancer vaccines in development are steadily advancing toward possible FDA approval, the vanguard of a new wave in cancer treatment.
See all headlines >>
CRI's Cancer Vaccine Consortium changes name to Cancer Immunotherapy Consortium
CRI – 3/18/10 – CRI's association of biopharmaceutical companies and academic institutions has changed it name to reflect better the program's scope and services to members developing immune system-based treatments for cancer.
See all headlines >>
Diagnostic tests planned to select patients most likely to benefit from skin cancer immunotherapy
GenomeWeb – 3/8/10 – GlaxoSmithKline and Abbott Molecular announced last week that they will work together to develop and commercialize a diagnostic test to select patients for an investigational skin cancer immunotherapy.
See all headlines >>
CRI researcher’s cancer immunotherapeutics formulation remains stable, potent
PharmaLive – 3/8/10 – Cancer-fighting bacterial vaccines from Advaxis maintain potency after long periods of storage, company reports.
See all headlines >>
Potential vaccine for rare cancer found safe
AHN – 3/4/10 – Researchers in the Netherlands say they have demonstrated the safety of a possible vaccine against mesothelioma, a lung cancer linked to asbestos exposure.
See all headlines >>
HPV vaccines may reduce a wide range of genital diseases
NewsRx – 3/4/10 – Vaccines that prevent infection by the human papillomavirus may result in rapid reduction of HPV-associated diseases, including cervical, vulvar, and vaginal cancers.
See all headlines >>
No meeting on Provenge prostate cancer vaccine needed, says FDA
AP – 3/2/10 – Shares of biotechnology company Dendreon Corp. jumped Tuesday after federal regulators said they don't plan to hold a public meeting on the company's prostate cancer treatment, possibly leading to quicker approval for the drug.
See all headlines >>
First therapeutic cancer vaccine approvals in 2010 “realistic expectation”
GenEngNews – 3/1/10 – Biopharma industry wonks expect the first therapeutic cancer vaccine approval to be among key advances in 2010.
See all headlines >>
CRI researchers report new technology that reveals how the immune system “sees” cancer
CRI – 3/1/10 – CRI researchers have taken a major step forward in identifying what the immune system “sees” on cancer cells, opening up new targets for cancer immunotherapy
See all headlines >>
Vaccine extends life of metastatic prostate cancer patients
BiotechDaily – 2/24/10 – In a newly published clinical trial, patients with metastatic prostate cancer who received a vaccine of harmless poxviruses engineered to trigger an immune system attack on prostate tumor cells lived considerably longer than patients who received a placebo vaccine.
See all headlines >>
CRI researchers detect an unexpected link between Hodgkin Lymphoma and reproductive germ cells
CRI – 2/24/10 – A new study by CRI scientists implicates genes active at the first stages of fetal development in the progression and spread of cancers.
See all headlines >>
CRI Young Philanthropists team up with Saks Fifth Avenue for spring event
CRI – 2/16/10 – The upcoming Spring Into Style benefit at Saks Fifth Avenue, organized by the CRI Young Philanthropists, fosters charitable giving and awareness among young professionals.
See all headlines >>
CRI announces new immune-related response criteria
CRI – 12/24/09 – An international collaboration of scientists from academia and industry have defined a new set of criteria that more accurately judges the therapeutic activity of immunological cancer treatments.
See all headlines >>
Patients respond to tumor-targeting drugs
USA Today – 12/11/09 – Drugs that target tumors are showing promise in advanced breast cancer.
See all headlines >>
Gene testing may improve cancer treatment
Web MD – 12/11/09 – Individualized care for ovarian cancer patients may stand to benefit from new genetic testing.
See all headlines >>
Spices may improve cancer treatment
US News – 12/11/09 – Pepper and turmeric contain compounds that have been shown to target tumor-promoting stem cells.
See all headlines >>
Breast cancer survivors may need to limit alcohol consumption
CNN – 12/10/09 – Breast cancer survivors who drank moderately had a higher risk of recurrence, a new study says.
See all headlines >>
Loneliness, isolation may impact cancer outcome
Time – 12/8/09 – The findings suggest that a cancer patient’s treatment should be a holistic approach.
See all headlines >>
Soy product, breast cancer link re-looked
CNN – 12/8/09 – In a new study, estrogen-rich soy products were shown to have a positive effect on breast cancer patients.
See all headlines >>
6-year decline in cancer deaths
BusinessWeek – 12/7/09 – The decline is attributable to early detection, decreases in smoking and improved treatments.
See all headlines >>
Mammograms not recommended between ages 40 and 50
ABC News – 11/18/09 – The United States Preventative Services Task Force is butting heads with doctors and organizations, like the American Cancer Society, on screening for breast cancer.
See all headlines >>
Cancer Research Institute profiled on Pathology.Org
CRI – 11/18/09 – Pathology.org, a Web site sharing health information on a range of subjects, has profiled CRI
See all headlines >>
Cancer is not so genetically easy to define
New York Times – 11/18/09 – An Icelandic human genome researcher has discovered that major diseases do not have a simple genetic pattern.
See all headlines >>
Ghostwriting and the manipulation of scientific literature
New York Times – 11/18/09 – A senator asks medical schools to explain their ghostwriting practices, a process that could be considered to some as plagiarism.
See all headlines >>
Targeting normal cells in or near tumors slows cancer growth
The Wistar Institute – 11/16/09 – CRI-funded researchers at The Wistar Institute show that taking the "soil" away from the cancer "seed" can slow its growth.
See all headlines >>
New Act passed to protect from genetic testing
New York Times – 11/16/09 – The Genetic Information Nondiscrimination Act will ban employers and insurers from using genetic testing to discriminate against an employee.
See all headlines >>
HDL cholesterol found to cut cancer risks
Bloomberg – 11/15/09 – The cholesterol that flushes clogged arteries also reduces the rate by which cancer develops.
See all headlines >>
Call for better, faster, and cheaper drug development
New York Times – 11/15/09 – Drug development is being relooked in order to save investors billions of dollars and years of development time.
See all headlines >>
Finding could reduce breast cancer metastasis
US News – 11/12/09 – Researchers have found a new target that may reduce the spread of breast cancer to the bone.
See all headlines >>
Gene therapy aims at cancer weakness
Science Blog – 11/12/09 – By inactivating a DNA repair gene, researchers have been able to take away certain tumor cells’ ability to repair themselves.
See all headlines >>
Spreading the news about clinical trials
ABC News – 11/10/09 – When the mainstream media picks up stories about new treatments for cancer, it has the potential to help more patients.
See all headlines >>
Breakthrough study - HPV vaccine
Cancer Research Institute – 11/9/09 – A breakthrough study reports complete and partial remissions after vaccinations.
See all headlines >>